卡地纳健康(CAH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CAH 卡地纳健康

休市中 09-18 16:00:00 EDT

225.38

-0.96

-0.42%

盘后229.10

+3.72+1.65%

19:51 EDT

最高226.12	最低221.70	成交量414.32万
今开225.29	昨收226.34	日振幅1.95%
总市值524.18亿	流通市值524.18亿	总股本2.33亿
成交额9.32亿	换手率1.78%	流通股本2.33亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CAH","market":"US","secType":"STK","nameCN":"卡地纳健康","latestPrice":225.38,"timestamp":1789761600000,"preClose":226.34,"halted":0,"volume":4143207,"hourTrading":{"tag":"盘后","latestPrice":229.1043,"preClose":225.38,"latestTime":"19:51 EDT","volume":523921,"amount":118081767.25212,"timestamp":1789775476652,"change":3.7243,"changeRate":0.016525,"amplitude":0.016525},"delay":0,"changeRate":-0.004241406733233224,"floatShares":232575728,"shares":232575728,"eps":7.23,"marketStatus":"休市中","change":-0.96,"latestTime":"09-18 16:00:00 EDT","open":225.29,"high":226.1197,"low":221.6974,"amount":932466562.82991,"amplitude":0.019538,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":7.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":428558400000,"exchange":"NYSE","adjPreClose":226.34,"dividendRate":0.009086,"preHourTrading":{"tag":"盘前","latestPrice":225.65,"preClose":226.34,"latestTime":"09:29 EDT","volume":537,"amount":121075.78437,"timestamp":1789738199999,"change":-0.69,"changeRate":-0.003049,"amplitude":0.010294},"postHourTrading":{"tag":"盘后","latestPrice":229.1043,"preClose":225.38,"latestTime":"19:51 EDT","volume":523921,"amount":118081767.25212,"timestamp":1789775476652,"change":3.7243,"changeRate":0.016525,"amplitude":0.016525},"volumeRatio":2.421613558593289,"impliedVol":0.2682,"impliedVolPercentile":0.2789},"requestUrl":"/m/hq/s/CAH","defaultTab":"news","newsList":[{"id":"1173341370","title":"异动解读｜卡地纳健康盘中上涨5.78%，Q4盈利大超预期叠加50亿美元回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1173341370","media":"行情直击","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173341370?lang=zh_cn&edition=full","pubTime":"2026-08-11 21:50","pubTimestamp":1786456234,"startTime":"0","endTime":"0","summary":"8月11日，卡地纳健康盘中上涨5.78%，报250.89美元/股，成交额1.19亿美元。更为关键的是，公司给出的财年前瞻指引调整后EPS为12.40至12.60美元，显著高于FactSet一致预期的12.08美元。与此同时，董事会批准追加50亿美元股票回购授权，为资本回报注入强劲信号。盈利大幅超预期叠加慷慨回购计划，共同推动股价走强。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"卡地纳健康盘中上涨5.78%，Q4盈利大超预期叠加50亿美元回购计划","news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198170476","title":"异动解读｜卡地纳健康盘前上涨3.29%，Q4盈利大超预期叠加50亿美元回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1198170476","media":"行情直击","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198170476?lang=zh_cn&edition=full","pubTime":"2026-08-11 18:56","pubTimestamp":1786445796,"startTime":"0","endTime":"0","summary":"8月11日，卡地纳健康盘前上涨3.29%，报242.6美元/股，成交额41.86万美元。更为关键的是，公司给出的财年前瞻指引调整后EPS为12.40至12.60美元，显著高于FactSet一致预期的12.08美元。与此同时，董事会批准追加50亿美元股票回购授权，为资本回报注入强劲信号。盈利大幅超预期叠加慷慨回购计划，共同推动股价盘前走强。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"卡地纳健康盘前上涨3.29%，Q4盈利大超预期叠加50亿美元回购计划","news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173999250","title":"卡地纳健康发布2026财年第四季度及全年业绩，并公布2027财年展望","url":"https://stock-news.laohu8.com/highlight/detail?id=1173999250","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173999250?lang=zh_cn&edition=full","pubTime":"2026-08-11 18:48","pubTimestamp":1786445327,"startTime":"0","endTime":"0","summary":"卡地纳健康（Cardinal Health）正式揭晓了其2026财年第四季度及整个财年的经营成果，同时，该公司还对外勾勒了2027财年的前瞻性指引。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310799852.SGD","LU1267930813.SGD","LU0792757196.USD","LU0072461881.USD","BK4585","LU1267930490.SGD","CAH","LU1880398554.USD","LU0052756011.USD","LU0211328371.USD","LU1880398471.USD","LU0310800965.SGD","LU0154236417.USD","LU0162691827.USD","LU0889566641.SGD","LU1983299246.USD","LU0128525689.USD","BK4588","BK4175","LU0211327993.USD","LU1571399168.USD","LU1267930227.SGD","SG9999001440.SGD","LU0006061336.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130666807","title":"卡地纳健康董事会批准追加500亿美元股票回购授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1130666807","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130666807?lang=zh_cn&edition=full","pubTime":"2026-08-11 18:48","pubTimestamp":1786445293,"startTime":"0","endTime":"0","summary":"卡地纳健康公司宣布，其董事会已正式批准一项高达50亿美元的增量股票回购授权。在获得此项新增授权后，卡地纳健康的整体回购能力得到了显著增强。尽管如此，该授权为卡地纳健康提供了极大的财务灵活性，使其能够在不影响核心运营及战略投资的前提下，积极管理资本结构。此次回购计划的批准，无疑为投资者注入了一剂强心针，短期内有望对股价形成支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","LU1267930813.SGD","LU0792757196.USD","LU1571399168.USD","SG9999001440.SGD","LU0310799852.SGD","BK4585","BK4175","LU0162691827.USD","LU0006061336.USD","LU0211327993.USD","LU0072461881.USD","LU1267930490.SGD","LU0128525689.USD","LU0052756011.USD","LU1267930227.SGD","BK4588","LU1880398471.USD","LU0310800965.SGD","LU1880398554.USD","LU0211328371.USD","LU1983299246.USD","CAH","LU0889566641.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147523608","title":"卡地纳健康提交SEC文件：新循环信贷额度取代原有364天、五年期及应收账款出售设施","url":"https://stock-news.laohu8.com/highlight/detail?id=1147523608","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147523608?lang=zh_cn&edition=full","pubTime":"2026-08-11 18:41","pubTimestamp":1786444877,"startTime":"0","endTime":"0","summary":"卡地纳健康通过SEC文件披露，公司已启用一项全新的循环信贷额度。此举旨在替代此前存在的三项融资安排：即364天信贷协议、五年期贷款设施，以及应收账款出售计划。这一变更标志着公司在资本结构优化方面的关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0154236417.USD","BK4588","LU0052756011.USD","LU1267930813.SGD","LU1880398471.USD","LU0792757196.USD","LU0211328371.USD","LU1267930490.SGD","LU1880398554.USD","BK4175","LU1571399168.USD","LU0211327993.USD","LU0072461881.USD","LU1267930227.SGD","LU0162691827.USD","LU0889566641.SGD","LU0310799852.SGD","LU0310800965.SGD","CAH","LU0128525689.USD","LU1983299246.USD","SG9999001440.SGD","LU0006061336.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168179405","title":"卡地纳健康：交易预计在完成后的首12个月内对调整后每股收益产生增厚效应","url":"https://stock-news.laohu8.com/highlight/detail?id=1168179405","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168179405?lang=zh_cn&edition=full","pubTime":"2026-07-21 04:48","pubTimestamp":1784580490,"startTime":"0","endTime":"0","summary":"卡地纳健康披露，相关交易预计将在完成后的首个12个月内，对公司的非公认会计准则每股收益产生增厚作用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006061336.USD","LU1571399168.USD","LU1267930490.SGD","SG9999001440.SGD","LU0310799852.SGD","LU0154236417.USD","LU1267930813.SGD","LU1267930227.SGD","LU0072461881.USD","LU1880398554.USD","AHCO","BK4585","BK4175","LU1983299246.USD","LU0310800965.SGD","CAH","BK4588","LU0211328371.USD","LU0792757196.USD","LU0128525689.USD","LU0162691827.USD","LU0889566641.SGD","LU0211327993.USD","LU0052756011.USD","LU1880398471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131849406","title":"异动解读 | 成本压力与增长放缓，卡地纳健康盘中大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131849406","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131849406?lang=zh_cn&edition=full","pubTime":"2026-04-30 21:39","pubTimestamp":1777556343,"startTime":"0","endTime":"0","summary":"卡地纳健康（CAH）今日盘中股价大跌5.33%，市场表现引人关注。消息面上，公司高管在电话会议中透露，与《通胀削减法案》相关的批发采购成本调整对公司整体增长率产生了下行压力。同时，尽管GLP-1类药物销量增长率仍保持在30%以上，但增长势头已较此前明显放缓。这些因素共同影响了市场对该公司短期增长前景的预期，可能是导致股价承压下跌的主要原因。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143971235","title":"卡地纳健康高管称《通胀削减法案》相关批发采购成本变动拖累整体增长率 - 电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1143971235","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143971235?lang=zh_cn&edition=full","pubTime":"2026-04-30 21:24","pubTimestamp":1777555477,"startTime":"0","endTime":"0","summary":"卡地纳健康高管在电话会议中透露，与《通胀削减法案》相关的批发采购成本调整对公司整体增长率产生了下行压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAH","LU0128525689.USD","BK4585","LU0889566641.SGD","LU0162691827.USD","LU0310799852.SGD","LU0211328371.USD","LU1880398554.USD","LU1267930490.SGD","BK4175","LU1267930813.SGD","LU0154236417.USD","LU0211327993.USD","LU0006061336.USD","LU1983299246.USD","LU1267930227.SGD","LU0052756011.USD","SG9999001440.SGD","BK4588","LU0792757196.USD","LU0072461881.USD","LU1880398471.USD","LU0310800965.SGD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135092418","title":"卡地纳健康高管：GLP-1药物销量增速仍超30%，但较此前有所放缓","url":"https://stock-news.laohu8.com/highlight/detail?id=1135092418","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135092418?lang=zh_cn&edition=full","pubTime":"2026-04-30 21:21","pubTimestamp":1777555302,"startTime":"0","endTime":"0","summary":"卡地纳健康公司高管在电话会议中透露，尽管GLP-1类药物销量增长率仍保持在30%以上，但增长势头已较此前明显放缓。\n该公司指出，这类用于糖尿病和肥胖症治疗的药物持续保持强劲需求，但市场扩张速度正在逐步回归理性区间。目前GLP-1药物业务仍是卡地纳健康重要的增长驱动力之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930813.SGD","LU0006061336.USD","LU0154236417.USD","LU1983299246.USD","BK4585","LU1267930490.SGD","SG9999001440.SGD","LU0889566641.SGD","LU0072461881.USD","BK4175","LU0211328371.USD","LU1267930227.SGD","LU1571399168.USD","LU0052756011.USD","LU0211327993.USD","LU1880398471.USD","CAH","LU0162691827.USD","LU0792757196.USD","LU0310800965.SGD","BK4588","LU0310799852.SGD","LU1880398554.USD","LU0128525689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136207744","title":"卡地纳健康扩大锕-225产能，以满足新型癌症疗法日益增长的需求","url":"https://stock-news.laohu8.com/highlight/detail?id=1136207744","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136207744?lang=zh_cn&edition=full","pubTime":"2026-04-01 19:01","pubTimestamp":1775041305,"startTime":"0","endTime":"0","summary":"为应对市场对创新癌症治疗手段不断攀升的需求，卡地纳健康已宣布扩大其放射性同位素锕-225的生产规模。此次产能提升旨在保障这种关键治疗材料的稳定供应，从而支持靶向放射性药物等前沿疗法的研发与应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006061336.USD","LU1571399168.USD","LU1267930490.SGD","SG9999001440.SGD","LU0310799852.SGD","LU0154236417.USD","LU1267930813.SGD","LU1267930227.SGD","LU0072461881.USD","LU1880398554.USD","BK4585","BK4175","LU0310800965.SGD","CAH","BK4588","LU0211328371.USD","LU0792757196.USD","LU0128525689.USD","LU0162691827.USD","LU0889566641.SGD","LU0211327993.USD","LU0052756011.USD","LU1880398471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175526367","title":"美股波动预期加剧，这些稳健的高股息股可为投资组合保驾护航","url":"https://stock-news.laohu8.com/highlight/detail?id=1175526367","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175526367?lang=zh_cn&edition=full","pubTime":"2025-02-20 15:12","pubTimestamp":1740035549,"startTime":"0","endTime":"0","summary":"随着2025年美股市场波动预期加剧，投资者或可考虑增持高股息股票以平滑投资风险。在市场波动时期，稳定派息股票常被视为“压舱石”，其股息收入能够在股价下跌时提供缓冲。其中，“股息贵族”尤其值得关注，这些公司已连续至少25年提高股息。此外，这些股票的股息率均高于标准普尔500指数1.24%的水平。该公司本月宣布计划拆分生命科学和诊断业务。今年以来该股股价微跌。年内股价下跌超6%，但目标价隐含18%上涨空间。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/daf8c6efec812c4e4d5211ffbcf205b8","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/daf8c6efec812c4e4d5211ffbcf205b8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美股波动预期加剧，这些稳健的高股息股可为投资组合保驾护航","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAH","FRT","PG","CVX","NEE","EMR","BDX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2509410816","title":"Gangtise投研日报 | 2025-02-05","url":"https://stock-news.laohu8.com/highlight/detail?id=2509410816","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509410816?lang=zh_cn&edition=full","pubTime":"2025-02-05 06:30","pubTimestamp":1738708200,"startTime":"0","endTime":"0","summary":"　　1．深圳机场预计2024年归属于上市公司股东的净利润为3.998亿元至4.438亿元，同比增长0.78%至11.88%。扣除非经常性损益后，预计净利润为2.961亿元至3.561亿元，同比增长289.24%至327.59%。基本每股收益预计为0.195元/股至0.2164元/股。经营态势良好，营业收入增幅远大于成本费用增幅。　　5． United Microelectronics Corporation 2024年第四季度业绩电话会：2024年第四季度，联电合并营收为504亿新台币，毛利率30.4%，股东应占净收入85亿新台币，每股收益4.682美元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-02-05/doc-ineiktkp5483790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BFTCPJ56.SGD","LU1880398471.USD","BK4017","UMC","LU1267930490.SGD","BK4175","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4585","LU0310799852.SGD","LU0211327993.USD","IE00B4R5TH58.HKD","BK4588","LU0162691827.USD","ROIC","BK4532","LINRF","SG9999001440.SGD","BK4526","LU0154236417.USD","LU1571399168.USD","LU1880398554.USD","CAH","LU0052756011.USD","LU0128525689.USD","LU0211331839.USD","LU0072461881.USD","LU1267930813.SGD","IE0002141913.USD","BK4231","BK4007","BK4168","LU1267930227.SGD","NESRF","LU0792757196.USD","LU0211328371.USD","BK4141","BK4554","LU0310800965.SGD","LU0889566641.SGD","IE0009355771.USD","LU0006061336.USD","BK4578","BK4080","IE00BJJMRZ35.SGD","NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508468929","title":"小摩：维持Cardinal Health(CAH.US)评级，由中性调整至中性评级, 目标价由142.00美元调整至145.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508468929","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508468929?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:13","pubTimestamp":1738681987,"startTime":"0","endTime":"0","summary":"小摩：维持Cardinal Health(CAH.US)评级，由中性调整至中性评级, 目标价由142.00美元调整至145.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/04231347949905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507644448","title":"Cardinal Health(CAH.US)：2025年Q2财报实现营收552.64亿美元，前值为574.45亿美元，预期值为549.7亿美元；每股收益为1.93美元，前值为1.89美元，预期值为1.76美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507644448","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507644448?lang=zh_cn&edition=full","pubTime":"2025-01-30 19:54","pubTimestamp":1738238063,"startTime":"0","endTime":"0","summary":"Cardinal Health(CAH.US)：2025年Q2财报实现营收552.64亿美元，前值为574.45亿美元，预期值为549.7亿美元；每股收益为1.93美元，前值为1.89美元，预期值为1.76美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/30195447908896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192403175","title":"Cardinal Health 2025年第二季度调整后每股收益$1.93击败$1.76预期，销售额$553亿击败$549.15亿预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1192403175","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192403175?lang=zh_cn&edition=full","pubTime":"2025-01-30 19:52","pubTimestamp":1738237978,"startTime":"0","endTime":"0","summary":"Cardinal Health 2025年第二季度调整后每股收益$1.93击败$1.76预期，销售额$553亿击败$549.15亿预期以上内容来自Benzinga Earnings专栏，原文如下：Cardinal Health Q2 2025 Adj. EPS $1.93 Beats $1.76 Estimate, Sales $55.3B Beat $54.915B Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cardinal Health 2025年第二季度调整后每股收益$1.93击败$1.76预期，销售额$553亿击败$549.15亿预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507042684","title":"富国银行：维持Cardinal Health(CAH.US)评级，由持股观望调整至持股观望评级, 目标价由127.00美元调整至135.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507042684","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507042684?lang=zh_cn&edition=full","pubTime":"2025-01-29 19:42","pubTimestamp":1738150962,"startTime":"0","endTime":"0","summary":"富国银行：维持Cardinal Health(CAH.US)评级，由持股观望调整至持股观望评级, 目标价由127.00美元调整至135.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29194247896901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502381667","title":"花旗：维持Cardinal Health(CAH.US)评级，由中性调整至中性评级, 目标价由120.00美元调整至129.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502381667","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502381667?lang=zh_cn&edition=full","pubTime":"2025-01-11 03:11","pubTimestamp":1736536303,"startTime":"0","endTime":"0","summary":"花旗：维持Cardinal Health(CAH.US)评级，由中性调整至中性评级, 目标价由120.00美元调整至129.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/11031147365003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502062017","title":"TD Cowen：上调Cardinal Health(CAH.US)评级，由持有调整至买入评级, 目标价由130.00美元调整至144.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502062017","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502062017?lang=zh_cn&edition=full","pubTime":"2025-01-09 02:03","pubTimestamp":1736359381,"startTime":"0","endTime":"0","summary":"TD Cowen：上调Cardinal Health(CAH.US)评级，由持有调整至买入评级, 目标价由130.00美元调整至144.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/09020347279995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CAH","TD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501208068","title":"Evercore ISI Group：上调Cardinal Health评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2501208068","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501208068?lang=zh_cn&edition=full","pubTime":"2025-01-07 19:36","pubTimestamp":1736249812,"startTime":"0","endTime":"0","summary":"evercore ISI Group：上调Cardinal Health(CAH.US)评级，由大市同步调整至优于大市评级,目标价由140.00美元调整至140.00美元。卡地纳健康(CAH.US)公司简介：卡地纳健康集团是一家医疗保健服务和产品公司，从事为医院、医疗保健系统、药房、门诊手术中心、临床实验室和医生办公室提供定制解决方案。它还提供医疗产品和药品以及具有成本效益的解决方案，以提高供应链效率。该公司通过制药和医疗部门运营。制药部门分销品牌和仿制药，专业药品和非处方医疗保健和消费品。医疗部门生产、采购和分销卡地纳健康品牌的医疗、外科和实验室产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107194539a218c113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107194539a218c113&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAH","EVR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492942352","title":"【券商聚焦】摩根士丹利：北美医疗保健服务行业MA预期改善 个股目标价及评级各有调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2492942352","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492942352?lang=zh_cn&edition=full","pubTime":"2024-12-18 10:37","pubTimestamp":1734489456,"startTime":"0","endTime":"0","summary":"摩根士丹利对这一领域的评级为“与市场一致”。此外，对于医疗保健技术和提供商，摩根士丹利建议保持选择性，因为需求和政策不确定性混合。对于行业中一些公司，摩根士丹利给出了以下评级和预期：对于Elevance Health Inc，摩根士丹利将其评级从“跑赢大市”下调至“与大市同步”，目标价从551美元降至388美元。对于Accolade Inc，目标价从6美元降至5美元，维持“与大市同步”评级。对于Cardinal Health Inc，目标价从127美元升至136美元，维持“跑赢大市”评级。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/OTE1MjMxNjI4NTkwNjg5MDI0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OTE1MjMxNjI4NTkwNjg5MDI0.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"283371","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUM","HCA","HCSG","ELV","ACCD","AMWL","VEEV","DGX","CAH","MA","GDRX","LFST"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cardinalhealth.com","stockEarnings":[{"period":"1week","weight":-0.0392},{"period":"1month","weight":-0.0403},{"period":"3month","weight":0.0163},{"period":"6month","weight":0.0844},{"period":"1year","weight":0.5021},{"period":"ytd","weight":0.0967}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0096},{"period":"3month","weight":0.02},{"period":"6month","weight":0.1744},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.117}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"卡地纳健康集团是一家成立于1979年的俄亥俄州公司，是一家全球整合的医疗服务和产品公司，为医院，医疗系统，药房，门诊手术中心，临床实验室，医师办公室和家庭患者提供定制化解决方案。该公司提供药品和医疗产品以及具有成本效益的解决方案，以提高供应链效率。该公司将患者，提供者，付款人，药剂师和制造商联系在一起，以实现综合护理协调和更好的患者管理。该公司管理其业务并报告其财务业绩，分为两个部分：制药和医疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.72093,"avgChangeRate":0.0383},{"month":2,"riseRate":0.697674,"avgChangeRate":0.015847},{"month":3,"riseRate":0.534884,"avgChangeRate":0.010705},{"month":4,"riseRate":0.395349,"avgChangeRate":-0.006028},{"month":5,"riseRate":0.627907,"avgChangeRate":0.020617},{"month":6,"riseRate":0.55814,"avgChangeRate":0.021029},{"month":7,"riseRate":0.581395,"avgChangeRate":0.005465},{"month":8,"riseRate":0.52381,"avgChangeRate":0.002666},{"month":9,"riseRate":0.5,"avgChangeRate":0.008688},{"month":10,"riseRate":0.488372,"avgChangeRate":-0.017903},{"month":11,"riseRate":0.697674,"avgChangeRate":0.03615},{"month":12,"riseRate":0.534884,"avgChangeRate":0.009388}],"exchange":"NYSE","name":"卡地纳健康","nameEN":"Cardinal Health"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"卡地纳健康(CAH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供卡地纳健康(CAH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"卡地纳健康,CAH,卡地纳健康股票,卡地纳健康股票老虎,卡地纳健康股票老虎国际,卡地纳健康行情,卡地纳健康股票行情,卡地纳健康股价,卡地纳健康股市,卡地纳健康股票价格,卡地纳健康股票交易,卡地纳健康股票购买,卡地纳健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"卡地纳健康(CAH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供卡地纳健康(CAH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}